BTIG Sticks to Its Hold Rating for Intuitive Surgical (ISRG)


BTIG analyst Ryan Zimmerman maintained a Hold rating on Intuitive Surgical (ISRG) yesterday. The company’s shares closed last Tuesday at $658.15, close to its 52-week high of $671.63.

According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of 12.2% and a 53.6% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Staar Surgical Company, and Zimmer Biomet Holdings.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Intuitive Surgical with a $579.29 average price target, implying a -13.2% downside from current levels. In a report issued on July 15, Leerink Partners also maintained a Hold rating on the stock with a $590.00 price target.

See today’s analyst top recommended stocks >>

Intuitive Surgical’s market cap is currently $77.85B and has a P/E ratio of 56.10. The company has a Price to Book ratio of 9.88.

Based on the recent corporate insider activity of 63 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ISRG in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts